Muhammad Husnain

842 total citations
69 papers, 467 citations indexed

About

Muhammad Husnain is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Muhammad Husnain has authored 69 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 17 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Muhammad Husnain's work include CAR-T cell therapy research (19 papers), Multiple Myeloma Research and Treatments (12 papers) and Lymphoma Diagnosis and Treatment (9 papers). Muhammad Husnain is often cited by papers focused on CAR-T cell therapy research (19 papers), Multiple Myeloma Research and Treatments (12 papers) and Lymphoma Diagnosis and Treatment (9 papers). Muhammad Husnain collaborates with scholars based in United States, Pakistan and Canada. Muhammad Husnain's co-authors include Irbaz Bin Riaz, Faiz Anwer, Ali McBride, Umar Zahid, Mitesh J. Borad, Daniel O. Persky, Hani M. Babiker, Kwan Lee, Ahmad Iftikhar and Onyee Chan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Muhammad Husnain

51 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Husnain United States 11 235 101 88 73 72 69 467
Ryuta Asada Japan 9 110 0.5× 49 0.5× 86 1.0× 128 1.8× 82 1.1× 20 503
Sarah Nagle United States 10 296 1.3× 68 0.7× 75 0.9× 28 0.4× 205 2.8× 29 503
Sumie Tabata Japan 13 137 0.6× 45 0.4× 96 1.1× 101 1.4× 141 2.0× 49 449
Michelle Wilkinson United Kingdom 13 172 0.7× 204 2.0× 60 0.7× 20 0.3× 31 0.4× 25 402
Laura Susok Germany 13 278 1.2× 76 0.8× 113 1.3× 25 0.3× 104 1.4× 64 612
Masahiro Yasui Japan 12 145 0.6× 26 0.3× 72 0.8× 86 1.2× 58 0.8× 40 404
Eiko Hayase Japan 13 162 0.7× 52 0.5× 177 2.0× 169 2.3× 37 0.5× 31 502
Paul Crotty Ireland 14 135 0.6× 71 0.7× 76 0.9× 29 0.4× 82 1.1× 28 517
Takuma Miura Japan 12 111 0.5× 58 0.6× 57 0.6× 81 1.1× 41 0.6× 42 441
Ryosei Nishimura Japan 11 252 1.1× 37 0.4× 162 1.8× 170 2.3× 33 0.5× 37 625

Countries citing papers authored by Muhammad Husnain

Since Specialization
Citations

This map shows the geographic impact of Muhammad Husnain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Husnain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Husnain more than expected).

Fields of papers citing papers by Muhammad Husnain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Husnain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Husnain. The network helps show where Muhammad Husnain may publish in the future.

Co-authorship network of co-authors of Muhammad Husnain

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Husnain. A scholar is included among the top collaborators of Muhammad Husnain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Husnain. Muhammad Husnain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barker, Kenneth N., et al.. (2025). Addition of Phosphorous and IL6 to m-EASIX Score Improves Detection of ICANS and CRS, as Well as CRS Progression. Cancers. 17(6). 918–918. 2 indexed citations
2.
Davis, Lisa E., et al.. (2024). Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer Chemotherapy and Pharmacology. 94(3). 361–372. 1 indexed citations
3.
4.
Husnain, Muhammad, et al.. (2023). Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?. Frontiers in Immunology. 14. 1329850–1329850. 3 indexed citations
5.
Mian, Agrima, Syed Arsalan Ahmed Naqvi, Muhammad Husnain, et al.. (2023). Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis. Leukemia Research. 131. 107324–107324. 7 indexed citations
6.
Naqvi, Syed Arsalan Ahmed, Mahmoud El Hajj, Christopher Rajkumar, et al.. (2023). Cardiovascular (CV) Mortality Among Adults Diagnosed with Leukemias: A Retrospective Cohort Study. Blood. 142(Supplement 1). 2426–2426. 2 indexed citations
7.
Hameed, Maha, et al.. (2023). Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects. Annals of Hematology. 103(6). 1859–1876.
8.
Davis, James A., et al.. (2022). Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature. Clinical Lymphoma Myeloma & Leukemia. 23(1). 15–21. 6 indexed citations
9.
10.
Husnain, Muhammad, Deukwoo Kwon, Michelle Saul, et al.. (2021). Clinical Outcomes in Acute Myeloid Leukemia (AML) Patients (Pts) Carrying Isocitrate Dehydrogenase (IDH1-2) Mutations Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). Transplantation and Cellular Therapy. 27(3). S147–S148. 1 indexed citations
11.
Husnain, Muhammad, et al.. (2021). Analysis of Pakistani and Indian Media towards Warfare: Case Study of Pulwama Attack & Balakot Airstrike. Turkish Online Journal of Qualitative Inquiry. 12(8).
12.
Wang, Jiasheng, et al.. (2020). Development of Nonbacterial Thrombotic Endocarditis While on Systemic Anticoagulation in Pancreatic Cancer: A Case Report. Cureus. 12(10). e10967–e10967. 4 indexed citations
13.
Alderuccio, Juan Pablo, Wei Zhao, Amrita Desai, et al.. (2019). Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation. American Journal of Hematology. 94(5). 585–596. 26 indexed citations
14.
Riaz, Irbaz Bin, Warda Faridi, Muhammad Husnain, et al.. (2019). Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 94(8). 1524–1534. 6 indexed citations
15.
Husnain, Muhammad, Wungki Park, Juan Carlos Ramos, et al.. (2018). Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection. Journal for ImmunoTherapy of Cancer. 6(1). 66–66. 21 indexed citations
16.
Babiker, Hani M., Irbaz Bin Riaz, Muhammad Husnain, & Mitesh J. Borad. (2017). Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma. PubMed. Volume 6. 11–18. 31 indexed citations
17.
Riaz, Irbaz Bin, et al.. (2017). Bone lymphoma with multiple negative bone biopsies. JAAPA. 30(9). 27–29.
18.
Riaz, Irbaz Bin, et al.. (2014). Recurrent Thrombosis in a Patient with Lesch-Nyhan Syndrome. The American Journal of Medicine. 127(7). e11–e12. 6 indexed citations
19.
Riaz, Irbaz Bin, Muhammad Husnain, Haris Riaz, et al.. (2014). Meta-Analysis of Revascularization Versus Medical Therapy for Atherosclerotic Renal Artery Stenosis. The American Journal of Cardiology. 114(7). 1116–1123. 37 indexed citations
20.
Riaz, Irbaz Bin, Abhijeet Dhoble, Chiu‐Hsieh Hsu, et al.. (2013). Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials. BMC Cardiovascular Disorders. 13(1). 116–116. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryuta Asada Breakdown of academic impact, for papers by Sarah Nagle Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Michelle Wilkinson Breakdown of academic impact, for papers by Laura Susok Breakdown of academic impact, for papers by Masahiro Yasui Breakdown of academic impact, for papers by Eiko Hayase Breakdown of academic impact, for papers by Paul Crotty Breakdown of academic impact, for papers by Takuma Miura Breakdown of academic impact, for papers by Ryosei Nishimura
Rankless by CCL
2026